Intellia Therapeutics (NTLA) Enterprise Value Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.15% |
| Dec 31, 2025 | 27.75% |
| Sep 30, 2025 | 14.86% |
| Jun 30, 2025 | 19.29% |
| Mar 31, 2025 | 16.18% |
| Dec 31, 2024 | 7.12% |
| Sep 30, 2024 | 6.23% |
| Jun 30, 2024 | -9.32% |
| Mar 31, 2024 | -10.65% |
| Dec 31, 2023 | -15.16% |
| Sep 30, 2023 | -27.96% |
| Jun 30, 2023 | -27.63% |
| Mar 31, 2023 | -55.09% |
| Dec 31, 2022 | -62.15% |
| Sep 30, 2022 | -42.55% |
| Jun 30, 2022 | -47.74% |
| Mar 31, 2022 | -162.85% |
| Dec 31, 2021 | -33.71% |
| Sep 30, 2021 | -39.63% |
| Jun 30, 2021 | -20.08% |
| Mar 31, 2021 | -21.23% |
| Dec 31, 2020 | -20.59% |
| Sep 30, 2020 | -22.44% |
| Jun 30, 2020 | -21.92% |
| Mar 31, 2020 | 0.95% |
| Dec 31, 2019 | -0.81% |
| Sep 30, 2019 | 0.54% |
| Jun 30, 2019 | 3.39% |
| Mar 31, 2019 | 9.81% |
| Dec 31, 2018 | -60.60% |
| Sep 30, 2018 | -52.54% |
| Jun 30, 2018 | -149.11% |
| Mar 31, 2018 | -160.80% |